Esterase‐Activated, pH‐Responsive, and Genetically Targetable Nano‐Prodrug for Cancer Cell Photo‐Ablation

Abstract

AbstractActivatable prodrugs have drawn considerable attention for cancer cell ablation owing to their high specificity in drug delivery systems. However, phototheranostic prodrugs with dual organelle‐targeting and synergistic effects are still rare due to low intelligence of their structures. Besides, the cell membrane, exocytosis, and diffusional hindrance by the extracellular matrix reduce drug uptake. Moreover, the up‐regulation of heat shock protein and short singlet‐oxygen lifetime in cancer cells hamper photo‐ablation efficacy, especially in the mono‐therapeutic model. To overcome those obstacles, we prepare an esterase‐activated DM nano‐prodrug, which is conjugated by diiodine‐substituted fluorogenic malachite green derivative (MG‐2I) and phototherapeutic agent DPP‐OH via hydrolyzable ester linkage, having pH‐responsiveness and genetically targetable activity for dual organelles‐targeting to optimize photo‐ablation efficacy. The DM nanoparticles (NPs) present improved pH‐responsive photothermal/photodynamic property by the protonation of diethylaminophenyl units in acidic environment. More importantly, the MG‐2I and DPP‐OH moieties can be released from DM nano‐prodrug through overexpressed esterase; then specifically target lysosomes and mitochondria in CT‐26 Mito‐FAP cells. Hence, near‐infrared DM NPs can trigger parallel damage in dual‐organelles with strong fluorescence and effective phototoxicity, thus inducing serious mitochondrial dysfunction and apoptotic death, showing excellent photo‐ablation effect based on esterase‐activated, pH‐responsive, and genetically targetable activities.